Bandar Alenezi

Employment

• Northern Border University Assistant Professor
  2011 - Present

Education

• University of Liverpool PhD in Pharmacology
  2018 - 2022
• University of Glasgow MSc. Clinical Pharmacology
  2014 - 2015
• Riyadh Elm University BSc. Pharmaceutical Sciences
  2007 - 2010

Projects & Funding

Projects & funding information is unavailable.

Publications (23)

• Aptasensors for NNK biomarkers in smoking-induced lung cancer
  Bandar Theyab Alenezi, Talha Jawaid, Zia ur Rehman +5 more
  Clinica Chimica Acta 2026 DOI: 10.1016/j.cca.2026.120891
  +Save
• Circulating integrins as biomarkers for bone metastasis in prostate cancer
  Bandar Theyab Alenezi, Abdullah R. Alzahrani, Zia ur Rehman +5 more
  Clinica Chimica Acta 2026 DOI: 10.1016/j.cca.2026.120894
  +Save
• From Mines To Medicines: The Role Of Community Pharmacists In Protecting Populations Near Phosphate Mining Sites
  EUROPEAN JOURNAL OF PROSTHODONTICS AND RESTORATIVE DENTISTRY 2026 DOI: 10.1922/EJPRD.V34I7S.1581
  +Save
• Green Mining, Medicine, And Sustainability: Community Pharmacists As Frontline Partners In Public Health Protection
  EUROPEAN JOURNAL OF PROSTHODONTICS AND RESTORATIVE DENTISTRY 2026 DOI: 10.1922/EJPRD.V34I7S.1582
  +Save
• Leveraging Mendelian Randomization and Genome-wide Association Data for Drug Repurposing in Heart Failure
  Asian Journal of Pharmaceutics 2026
  +Save
• Prevalence of polypharmacy in elderly patients with chronic diseases in Arar City, Kingdom of Saudi Arabia
  Annals of Clinical and Analytical Medicine 2026 DOI: 10.4328/ACAM.22833
  +Save
• Clinical Outcomes in Patients with Cystic Fibrosis Receiving CFTR Modulators: A Comparison of Childhood Versus Adolescent Initiation
  Children 2025 DOI: 10.3390/children12020157
  +Save
• Assessing the Impact of Compliance and Health Literacy on the Management of Chronic Diseases in the City of Arar, KSA
  GLOBAL JOURNAL OF MEDICAL PHARMACEUTICAL AND BIOMEDICAL UPDATE 2025 DOI: 10.25259/GJMPBU_58_2024
  +Save
• Molecular dynamics of inflammation resolution: therapeutic implications
  Frontiers in Cell and Developmental Biology 2025 DOI: 10.3389/fcell.2025.1600149
  +Save
• NEGLECTED TROPICAL DISEASES: CURRENT TREATMENT CHALLENGES AND FUTURE THERAPEUTIC POTENTIALS
  PROSPECTS IN PHARMACEUTICAL SCIENCES 2025 DOI: 10.56782/PPS.295
  +Save
• The Assessment of Students’ Perception Regarding the Learning Experience in the Virtual Pharmacology Laboratory
  Dubai Medical Journal 2025 DOI: 10.18502/dmj.v8i1.18316
  +Save
• Knowledge and Attitude Towards Botulinum Toxin Use in Cosmetic Injections Among the Arar Population in Saudi Arabia: A Cross-Sectional Study.
  Cureus 2024 DOI: 10.7759/cureus.70694
  +Save
• Beyond Glycemic Control: GLP-1 Receptor Agonists and Their Impact on Calcium Homeostasis in Real-World Patients
  Journal of Clinical Medicine 2024 DOI: 10.3390/jcm13164896
  +Save
• Experimental treatment efficacy of dmrFABP5 on prostate cancer singly or in combination with drugs in use.
  American journal of cancer research 2024
  +Save
• Experimental treatment efficacy of dmrFABP5 on prostate cancer singly or in combination with drugs in use
  AMERICAN JOURNAL OF CANCER RESEARCH 2024
  +Save
• Risperidone-induced bioenergetic disruption in the isolated human peripheral blood monocytes
  TOXICOLOGY IN VITRO 2024 DOI: 10.1016/J.TIV.2024.105936
  +Save
• FABP5 can substitute for androgen receptor in malignant progression of prostate cancer cells
  International Journal of Oncology 2023 DOI: 10.3892/ijo.2023.5606
  +Save
• Experimental Treatment Efficacy of dmrFABP5 on Prostate Cancer Singly or in Combination with Drugs in Use
  2023 DOI: 10.20944/preprints202307.0924.v1
  +Save
• Molecular mechanisms on how FABP5 inhibitors promote apoptosis‐induction sensitivity of prostate cancer cells
  Cell Biology International 2023 DOI: 10.1002/cbin.11989
  +Save
• Experimental treatment of prostate cancer through knocking out
  2022
  +Save